机构:[1]Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province 610041, China四川大学华西医院[2]Institute of Clinical Pathology, West China Hospital of Sichuan University, Chengdu 610041, China四川大学华西医院[3]Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China四川大学华西医院[4]Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China四川大学华西医院[5]Department of Hepato-biliary-pancrease, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, China[6]Department of Hepatopancreatobiliary Surgery, Meishan City People’s Hospital, Meishan Hospital of West China Hospital, Sichuan University, Meishan 620000, China
National Natural Science Foundation
of China (No. 82203785 and 82270648), the China Postdoctoral Science
Foundation (No. 2022M712263), the Post-Doctor Research Project, West China
Hospital, Sichuan University (Nos. 2020HXBH076), and the Key Technology
Research and Development Program of the Sichuan Province (Nos.
2021YFSY0009 and 2021YFS0106).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区肿瘤学
第一作者:
第一作者机构:[1]Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province 610041, China
通讯作者:
通讯机构:[1]Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province 610041, China[6]Department of Hepatopancreatobiliary Surgery, Meishan City People’s Hospital, Meishan Hospital of West China Hospital, Sichuan University, Meishan 620000, China
推荐引用方式(GB/T 7714):
Xu Liangliang,Wang Peng,Li Li,et al.circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma[J].Molecular cancer.2023,22(1):174.doi:10.1186/s12943-023-01882-z.
APA:
Xu Liangliang,Wang Peng,Li Li,Li Lian,Huang Yang...&Xu Mingqing.(2023).circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.Molecular cancer,22,(1)
MLA:
Xu Liangliang,et al."circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma".Molecular cancer 22..1(2023):174